PHAT vs SWK · rev $132.6M vs P/E 34, rev $7.81B
Phathom Pharmaceuticals Inc (PHAT) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported PHAT revenue for 2026-06-30 was $132.6M. Net income was -$48.0M. PHAT currently screens at market cap $622.7M.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
PHAT currently screens at market cap $622.7M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the PHAT and SWK stock pages for the full models.
Not investment advice.